Avalon Ventures XI L.P. 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:58 pm Sale |
2024-11-06 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 2,146,482 4.100% |
-1,943,836 (-47.52%) |
Filing |
| 2024-10-25 5:28 pm Sale |
2024-10-23 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 4,090,318 7.800% |
-548,408 (-11.82%) |
Filing |
| 2024-10-22 4:16 pm Sale |
2024-10-18 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 4,638,726 8.900% |
-1,983,341 (-29.95%) |
Filing |
| 2024-09-16 9:41 pm Sale |
2024-09-12 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 6,622,067 12.700% |
-682,423 (-9.34%) |
Filing |
| 2024-06-05 7:28 pm Sale |
2024-06-03 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 7,304,490 14.100% |
-1,496,249 (-17.00%) |
Filing |
| 2024-03-04 8:07 pm Sale |
2024-02-29 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 8,800,739 17.100% |
-965,615 (-9.89%) |
Filing |
| 2023-11-15 6:22 pm Purchase |
2023-11-13 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 9,766,354 21.200% |
869,645 (+9.77%) |
Filing |
| 2021-06-25 06:07 am Purchase |
2021-06-15 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 8,896,709 21.400% |
8,896,709 (New Position) |
Filing |